Fentanyl in the Cath Lab: Routine but Risky? Fentanyl in the Cath Lab: Routine but Risky?

New data show the potent intravenous opiate weakens the antiplatelet effects of ticagrelor during PCI, challenging its routine and prophylactic use for cardiac catheterization and PCI in the US.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news